BRCA1 and/or BRCA2 mutations (BRCAm) are established mechanisms of homologous recombination deficiencies (HRDs) known to play a role in ovarian cancer and may be germline (g) or somatic (s) in origin. The gene discussed is BRCA1; the disease is ovarian carcinoma.